Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082203193> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2082203193 endingPage "16" @default.
- W2082203193 startingPage "9" @default.
- W2082203193 abstract "Patients with atopic dermatitis present with debilitating symptoms, including pruritus and subsequent excoriation, which significantly reduces their quality of life (QOL). At present, the standard therapy for atopic dermatitis constitutes a topical steroid and/or a topical immunomodulator, an emollient and an oral antihistamine, although few studies have reported the effect of this treatment regimen on QOL. The current study aimed to verify the efficacy of the standard therapy for both clinical symptom severity and patient QOL, assessed using the validated Skindex-16 questionnaire. Atopic dermatitis patients receiving the standard therapy (n=771) were enrolled in the current phase IV, multicenter, 12-week, open-label study. The Rajka and Langeland scale (used to rate the severity of atopic dermatitis symptoms) and the Skindex-16 QOL questionnaire were completed at weeks 0 (baseline), 4 and 12. Of 415 patients completing the questionnaire at all time points (per-protocol population), 95.2% were prescribed the antihistamine fexofenadine HCl 60 mg. There were significant improvements in symptoms, emotions and functioning scale scores at weeks 4 and 12 compared with baseline (P<0.005). Discomfort associated with itching, as assessed by item 1 on the Skindex-16, improved over the treatment period (score decreased by >or=1 and >or=2 in 75.2% and 50.9% of patients, respectively). Significant (P<0.005) improvements from baseline in global scores were also observed at weeks 4 and 12, and for week 12 compared with week 4. Severity scores improved significantly (P<0.005) from weeks 0-4 and from weeks 4-12. The standard therapy was generally well tolerated with only mild adverse events reported (0.5%). These data suggest that patients with atopic dermatitis and associated pruritus experience significant improvements in both symptom severity and QOL when receiving standard therapy." @default.
- W2082203193 created "2016-06-24" @default.
- W2082203193 creator A5044934384 @default.
- W2082203193 creator A5089068986 @default.
- W2082203193 date "2006-12-20" @default.
- W2082203193 modified "2023-10-15" @default.
- W2082203193 title "Effect of standard medication on quality of life of patients with atopic dermatitis" @default.
- W2082203193 cites W1976665465 @default.
- W2082203193 cites W1999174354 @default.
- W2082203193 cites W2015166934 @default.
- W2082203193 cites W2020903065 @default.
- W2082203193 cites W2024687543 @default.
- W2082203193 cites W2047826027 @default.
- W2082203193 cites W2049515151 @default.
- W2082203193 cites W2057721135 @default.
- W2082203193 cites W2069077005 @default.
- W2082203193 cites W2073746524 @default.
- W2082203193 cites W2088529808 @default.
- W2082203193 cites W2109822050 @default.
- W2082203193 cites W2143138262 @default.
- W2082203193 cites W4319293042 @default.
- W2082203193 doi "https://doi.org/10.1111/j.1346-8138.2007.00209.x" @default.
- W2082203193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17204095" @default.
- W2082203193 hasPublicationYear "2006" @default.
- W2082203193 type Work @default.
- W2082203193 sameAs 2082203193 @default.
- W2082203193 citedByCount "24" @default.
- W2082203193 countsByYear W20822031932012 @default.
- W2082203193 countsByYear W20822031932014 @default.
- W2082203193 countsByYear W20822031932016 @default.
- W2082203193 countsByYear W20822031932018 @default.
- W2082203193 countsByYear W20822031932019 @default.
- W2082203193 countsByYear W20822031932022 @default.
- W2082203193 countsByYear W20822031932023 @default.
- W2082203193 crossrefType "journal-article" @default.
- W2082203193 hasAuthorship W2082203193A5044934384 @default.
- W2082203193 hasAuthorship W2082203193A5089068986 @default.
- W2082203193 hasConcept C126322002 @default.
- W2082203193 hasConcept C159110408 @default.
- W2082203193 hasConcept C16005928 @default.
- W2082203193 hasConcept C2776173921 @default.
- W2082203193 hasConcept C2776711289 @default.
- W2082203193 hasConcept C2776880894 @default.
- W2082203193 hasConcept C2778329239 @default.
- W2082203193 hasConcept C2779923671 @default.
- W2082203193 hasConcept C2779951463 @default.
- W2082203193 hasConcept C2780501606 @default.
- W2082203193 hasConcept C2780564577 @default.
- W2082203193 hasConcept C42219234 @default.
- W2082203193 hasConcept C535046627 @default.
- W2082203193 hasConcept C71924100 @default.
- W2082203193 hasConcept C98274493 @default.
- W2082203193 hasConceptScore W2082203193C126322002 @default.
- W2082203193 hasConceptScore W2082203193C159110408 @default.
- W2082203193 hasConceptScore W2082203193C16005928 @default.
- W2082203193 hasConceptScore W2082203193C2776173921 @default.
- W2082203193 hasConceptScore W2082203193C2776711289 @default.
- W2082203193 hasConceptScore W2082203193C2776880894 @default.
- W2082203193 hasConceptScore W2082203193C2778329239 @default.
- W2082203193 hasConceptScore W2082203193C2779923671 @default.
- W2082203193 hasConceptScore W2082203193C2779951463 @default.
- W2082203193 hasConceptScore W2082203193C2780501606 @default.
- W2082203193 hasConceptScore W2082203193C2780564577 @default.
- W2082203193 hasConceptScore W2082203193C42219234 @default.
- W2082203193 hasConceptScore W2082203193C535046627 @default.
- W2082203193 hasConceptScore W2082203193C71924100 @default.
- W2082203193 hasConceptScore W2082203193C98274493 @default.
- W2082203193 hasIssue "1" @default.
- W2082203193 hasLocation W20822031931 @default.
- W2082203193 hasLocation W20822031932 @default.
- W2082203193 hasOpenAccess W2082203193 @default.
- W2082203193 hasPrimaryLocation W20822031931 @default.
- W2082203193 hasRelatedWork W2007665779 @default.
- W2082203193 hasRelatedWork W2048836398 @default.
- W2082203193 hasRelatedWork W2049229814 @default.
- W2082203193 hasRelatedWork W2066897677 @default.
- W2082203193 hasRelatedWork W2359829263 @default.
- W2082203193 hasRelatedWork W2368651658 @default.
- W2082203193 hasRelatedWork W2391585213 @default.
- W2082203193 hasRelatedWork W2889824670 @default.
- W2082203193 hasRelatedWork W2989772907 @default.
- W2082203193 hasRelatedWork W4211022481 @default.
- W2082203193 hasVolume "34" @default.
- W2082203193 isParatext "false" @default.
- W2082203193 isRetracted "false" @default.
- W2082203193 magId "2082203193" @default.
- W2082203193 workType "article" @default.